Evidence map›Paper›PMID 30700530›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2019

Conditional BDNF Delivery from Astrocytes Rescues Memory Deficits, Spine Density, and Synaptic Properties in the 5xFAD Mouse Model of Alzheimer Disease.

Benoit de Pins, Carmen Cifuentes-Díaz, Amel Thamila Farah, Laura López-Molina, Enrica Montalban, Anna Sancho-Balsells, Ana López, Silvia Ginés, José María Delgado-García, Jordi Alberch and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 128 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
128citing papers in PubMed, 4 pooled it
11.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

128 citing papers in PubMed, 4 syntheses or guidelines pooled it, 200 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Astrocytes in Multiple Sclerosis: Getting to the Core.International journal of molecular sciences · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Disruption of BDNF signalling in neuropathologies.Biochemical Society transactions · 2026
    Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. RoastedAntioxidants (Basel, Switzerland) · 2025
    Article
  18. Article
  19. Article
  20. Article

68 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 2 countries.

Benoit de PinsInstitut National de la Santé et de la Recherche Médicale Unité Mixte de Recherche-S 839, Paris, France.ORCID 0000-0002-6779-8446
Carmen Cifuentes-DíazInstitut National de la Santé et de la Recherche Médicale Unité Mixte de Recherche-S 839, Paris, France.ORCID 0000-0003-2563-2082
Amel Thamila FarahInstitut National de la Santé et de la Recherche Médicale Unité Mixte de Recherche-S 839, Paris, France.
Laura López-MolinaDepartament de Biomedicina, Facultat de Medicina, Institut de Neurociències, Universitat de Barcelona, Barcelona, 08036 Spain.
Enrica MontalbanInstitut National de la Santé et de la Recherche Médicale Unité Mixte de Recherche-S 839, Paris, France.
Anna Sancho-BalsellsDepartament de Biomedicina, Facultat de Medicina, Institut de Neurociències, Universitat de Barcelona, Barcelona, 08036 Spain.ORCID 0000-0003-2053-7211
Ana LópezDepartament de Biomedicina, Facultat de Medicina, Institut de Neurociències, Universitat de Barcelona, Barcelona, 08036 Spain.
Silvia GinésDepartament de Biomedicina, Facultat de Medicina, Institut de Neurociències, Universitat de Barcelona, Barcelona, 08036 Spain.ORCID 0000-0002-9479-8185
José María Delgado-GarcíaDivision of Neurosciences, Pablo de Olavide University, Seville 41013, Spain.ORCID 0000-0001-7369-4195
Jordi AlberchDepartament de Biomedicina, Facultat de Medicina, Institut de Neurociències, Universitat de Barcelona, Barcelona, 08036 Spain.
Agnès GruartDivision of Neurosciences, Pablo de Olavide University, Seville 41013, Spain.ORCID 0000-0002-2309-0323
Jean-Antoine GiraultInstitut National de la Santé et de la Recherche Médicale Unité Mixte de Recherche-S 839, Paris, France.ORCID 0000-0002-7900-1705
Albert GiraltDepartament de Biomedicina, Facultat de Medicina, Institut de Neurociències, Universitat de Barcelona, Barcelona, 08036 Spain, albertgiralt@ub.edu.ORCID 0000-0001-5334-0963
Biomedical Research Networking Center on Neurodegenerative Diseases · ESInserm · FRInstitut du Fer à Moulin · FRUniversidad Pablo de Olavide · ESUniversitat de Barcelona · ESConsorci Institut D'Investigacions Biomediques August Pi I Sunyer · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It has been well documented that neurotrophins, including brain-derived neurotrophic factor (BDNF), are severely affected in Alzheimer's disease (AD), but their administration faces a myriad of technical challenges. Here we took advantage of the early astrogliosis observed in an amyloid mouse model of AD (5xFAD) and used it as an internal sensor to administer BDNF conditionally and locally. We first demonstrate the relevance of BDNF release from astrocytes by evaluating the effects of coculturing WT neurons and BDNF-deficient astrocytes. Next, we crossed 5xFAD mice with pGFAP:BDNF mice (only males were used) to create 5xFAD mice that overexpress BDNF when and where astrogliosis is initiated (5xF:pGB mice). We evaluated the behavioral phenotype of these mice. We first found that BDNF from astrocytes is crucial for dendrite outgrowth and spine number in cultured WT neurons. Double-mutant 5xF:pGB mice displayed improvements in cognitive tasks compared with 5xFAD littermates. In these mice, there was a rescue of BDNF/TrkB downstream signaling activity associated with an improvement of dendritic spine density and morphology. Clusters of synaptic markers, PSD-95 and synaptophysin, were also recovered in 5xF:pGB compared with 5xFAD mice as well as the number of presynaptic vesicles at excitatory synapses. Additionally, experimentally evoked LTP

Indexed as

Neuronal PlasticityAlzheimer DiseaseAnimalsAstrocytesBrain-Derived Neurotrophic FactorCells, CulturedDendritic SpinesDisease Models, AnimalHippocampusMaleMemory DisordersMice, KnockoutBdnf protein, mouseBrain-Derived Neurotrophic FactorAlzheimer's diseaseastrocytesBDNFlong-term potentiationmemorymice

Identifiers

PMID30700530
PMCPMC6435824
OpenAlexW2912162449

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.